题目内容
(请给出正确答案)
[单选题]
根据2019WCLC上公布的SHR1210-III-303研究结果,ITT人群中卡瑞利珠单抗联合化疗组的DCR是?()
A.87.3%
B.84.6%
C.74.4%
D.70.4%
查看答案
如果结果不匹配,请 联系老师 获取答案
A.87.3%
B.84.6%
C.74.4%
D.70.4%
A.17.6个月
B.9.9个月
C.11.2个月
D.7.8个月
A.5.68个月
B.6.18个月
C.6.48个月
D.7.12个月
A.SHR1210-II-201,2019WCLC
B.SHR1210-II-202,2019ASCO
C.SHR1210-III-303,2019WCLC
D.SHR1210-III-303,2019ASCO